These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 23970641)
1. Challenges in implementing the new BASHH guidelines for the management of gonorrhoea. Rodgers S; Murgatroyd M; Perez K; Kingston M; Lee V Int J STD AIDS; 2014 Feb; 25(2):145-7. PubMed ID: 23970641 [TBL] [Abstract][Full Text] [Related]
2. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia. Hustig A; Bell C; Waddell R Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709 [TBL] [Abstract][Full Text] [Related]
3. UK national guideline for the management of gonorrhoea in adults, 2011. Bignell C; Fitzgerald M; ; Int J STD AIDS; 2011 Oct; 22(10):541-7. PubMed ID: 21998172 [TBL] [Abstract][Full Text] [Related]
4. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Unemo M; Golparian D; Hestner A Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645 [TBL] [Abstract][Full Text] [Related]
5. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Unemo M; Golparian D; Potočnik M; Jeverica S Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003 [TBL] [Abstract][Full Text] [Related]
6. The 2018-19 International Union against Sexually Transmitted Infections European Collaborative Clinical Group report on the diagnosis and treatment of gonorrhoea in Europe. Clarke E; Patel C; Patel R; Unemo M; Int J STD AIDS; 2020 Jan; 31(1):77-81. PubMed ID: 31793388 [No Abstract] [Full Text] [Related]
7. Adherence to the 2012 European gonorrhoea guideline in the WHO European Region according to the 2018-19 International Union against Sexually Transmitted Infections European Collaborative Clinical Group gonorrhoea survey. Unemo M; Clarke E; Boiko I; Patel C; Patel R; Int J STD AIDS; 2020 Jan; 31(1):69-76. PubMed ID: 31842695 [No Abstract] [Full Text] [Related]
8. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Ison CA; Hussey J; Sankar KN; Evans J; Alexander S Euro Surveill; 2011 Apr; 16(14):. PubMed ID: 21492528 [TBL] [Abstract][Full Text] [Related]
9. Background review for the '2020 European guideline for the diagnosis and treatment of gonorrhoea in adults'. Unemo M; Ross J; Serwin AB; Gomberg M; Cusini M; Jensen JS Int J STD AIDS; 2021 Feb; 32(2):108-126. PubMed ID: 33323071 [TBL] [Abstract][Full Text] [Related]
10. CDC update on gonorrhea: expand treatment to limit resistance. Campos-Outcalt D J Fam Pract; 2011 Dec; 60(12):736-40. PubMed ID: 22163356 [No Abstract] [Full Text] [Related]
11. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection. Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490 [TBL] [Abstract][Full Text] [Related]
12. Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial. Chen MY; McNulty A; Avery A; Whiley D; Tabrizi SN; Hardy D; Das AF; Nenninger A; Fairley CK; Hocking JS; Bradshaw CS; Donovan B; Howden BP; Oldach D; Lancet Infect Dis; 2019 Aug; 19(8):833-842. PubMed ID: 31196813 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of Turner KM; Christensen H; Adams EJ; McAdams D; Fifer H; McDonnell A; Woodford N BMJ Open; 2017 Jun; 7(6):e015447. PubMed ID: 28615273 [TBL] [Abstract][Full Text] [Related]
14. Does the '2012 IUSTI ECCG report on the diagnosis and management of Neisseria gonorrhoeae infections in Europe' depict the situation in Europe? Unemo M; Brooks B; Cole M; Ross JD; White JA; Patel R; Int J STD AIDS; 2013 Jun; 24(6):423-6. PubMed ID: 23970742 [TBL] [Abstract][Full Text] [Related]
15. Frequency of Nucleic Acid Amplification Test Positivity Among Men Who Have Sex With Men Returning for a Test-of-Cure Visit 7 to 30 Days After Treatment of Laboratory-Confirmed Neisseria gonorrhoeae Infection at 2 Public Sexual Health Clinics, New York City, 2013 to 2016. Okah E; Westheimer EF; Jamison K; Schillinger JA Sex Transm Dis; 2018 Mar; 45(3):177-182. PubMed ID: 29420445 [TBL] [Abstract][Full Text] [Related]
16. Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance. Chen PL; Hsieh YH; Lee HC; Ko NY; Lee NY; Wu CJ; Chang CM; Lee CC; Ko WC Int J STD AIDS; 2009 Apr; 20(4):225-8. PubMed ID: 19304963 [TBL] [Abstract][Full Text] [Related]
17. The outcome of oropharyngeal gonorrhoea treatment with different regimens. Manavi K; Young H; McMillan A Int J STD AIDS; 2005 Jan; 16(1):68-70. PubMed ID: 15705277 [TBL] [Abstract][Full Text] [Related]
18. Gonorrhoea in 21st century--international and Polish situation. Serwin AB; Koper M; Unemo M Przegl Epidemiol; 2014; 68(1):39-44, 127-31. PubMed ID: 25004630 [TBL] [Abstract][Full Text] [Related]
19. Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study. Hananta IPY; De Vries HJC; van Dam AP; van Rooijen MS; Soebono H; Schim van der Loeff MF Sex Transm Infect; 2017 Nov; 93(7):467-471. PubMed ID: 28822976 [TBL] [Abstract][Full Text] [Related]
20. Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 May; 60(18):579-81. PubMed ID: 21566558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]